Uppsala Monitoring Centre

04/05/2026

Harnessing to improve safe dosing of high-risk drugs 🤖

An Australian research team shares how they're turning to to improve the safe dosing of unfractionated heparin (UFH), an anticoagulant that is notoriously difficult to dose correctly and linked to serious side effects. They hope their work will lead to more sophisticated dosing strategies that enhance the safety and effectiveness of care in everyday clinical practice.

Read for the full story at the link below👇

An Australian research team is using artificial intelligence to improve the safe dosing of unfractionated heparin, a high-risk drug linked to serious side effects.

03/05/2026

📣 Our global family is growing – welcome to Myanmar🇲🇲 who joins the World Health Organization (WHO) Programme for International Drug Monitoring (PIDM) as the 161st member!

The WHO PIDM provides a forum for WHO member states, territories, and areas to work together to improve medicines and vaccine safety. By sharing national insights, members help strengthen safety surveillance around the world.

Read more here 👉 ow.ly/LRxp50FnvQV

01/05/2026

The podcast brings intriguing and inspiring stories from the world of right to your ears. Some of our latest episodes cover:

🔎 Disproportionality analyses – Michele Fusaroli & Eugene van Puijenbroek
🩻 Medical devices, part 1 and 2 – Omar Aimer
🌐 The WHO Global Smart PV Strategy – Shanthi Pal

🎧 Listen now at 👉 https://www.drugsafetymatterspod.org

01/05/2026

We’re an Outreach Specialist to help strengthen the reach and impact of UMC’s products and services in global .

As a member of our Outreach section, you will support and further develop UMC’s external engagement work through various activities, including events, email campaigns, projects, and close collaboration with our user communities.

Read more about this exciting opportunity and apply by 22 May 2026 here 👉 https://ow.ly/bQLe50YT6nY

30/04/2026

Anti-vaccination belief and vaccine hesitancy are not one and the same. Understanding this difference is critical to effective public health communication strategies.

This , we look back into the archives to explore how countering narratives of distrust can help persuade those hesitant about vaccines.

Read more 👉 https://ow.ly/NTwl50YSluY

30/04/2026

Did you know that anyone can report a suspected side effect to a medicine or vaccine?

These reports are a vital source of information for regulators and scientists to identify emerging safety issues. By reporting suspected side effects, we can all contribute to the safer use of medicines and vaccines for everyone everywhere.

👀 Follow Lisa's journey through the this to learn more 👉 ow.ly/EoZ950LOJE4

En español: ow.ly/Tmtu50LOJMi
En français: ow.ly/PGKr50NiCQg
Em português: ow.ly/nshb50VzPKM
بالعربية: ow.ly/OiSY50Rn3Ts

28/04/2026

How is UMC's drug dictionary supporting clinical and workflows at a national scale?

Instituto Butantan is Brazil🇧🇷's leading manufacturer of vaccines and heterologous immunoglobulins, supporting the country's national immunisation program. They're also the largest producer of immunobiologicals in Latin America.

Maria Beatriz Bastos Lucchesi, Marcelo Eiji Koike, and Clarissa Leite Santos share Butantan’s experience with the ecosystem in . Read their article this 👉 https://ow.ly/Znqu50YQooP

🎥 Watch our interview with Maria below👇

27/04/2026

Join UMC as a temporary Customer Liaison Specialist and support customer lifecycle processes within an international life science environment.

As a member of our Customer Liaison team, you will plan, track, and support annual customer reviews, renewals, and offboarding. You will also work closely with Customer Engagement to support customer relationship activities.

This position is offered on a substitute fixed-term basis until August 2027.

Submit your application by 8 May 2026 👉 https://ow.ly/Cgkp50YQ6ic

27/04/2026

💉 The changing landscape of vaccine surveillance has prompted the development of innovative tools and standardised mechanisms to remove barriers to collecting reports of adverse events following immunisation (AEFI) and monitoring the safety of vaccines.

Learn how UMC supports members of the WHO Programme for International Drug Monitoring (PIDM) to strengthen their surveillance systems and keep patient safety in focus in the film below 📽️

24/04/2026

💉 It's !

Vaccines have long been one of the most powerful tools in , helping to protect people and their communities from vaccine-preventable diseases for generations.

Safety surveillance, public awareness, and sharing accurate information are crucial to building trust and ensuring for generations to come.

Have questions about vaccines? Visit the World Health Organization (WHO)'s Vaccine Information Hub for evidence-based information and resources 👉 https://ow.ly/l5hv50YOVzR

23/04/2026

Contributing to patient safety and beating hearts through 🫀

From a stent threaded into a coronary artery to an ECG monitor, most patients at Instituto Nacional de Cardiología Ignacio Chávez (INC), a cardiology hospital in Mexico🇲🇽, will encounter a during their treatment. To better detect, analyse, and monitor medical device-related incidents, the IMC implemented a dedicated technovigilance centre.

Learn how the INC's efforts have gone beyond detecting safety problems to actively preventing medical device-related harm and keeping hearts beating in 👉 https://ow.ly/BR1S50YNPC4

22/04/2026

Routine health data, including register-based health records, are a complementary resource in signal detection and assessment, yet remain underutilized in real-world signal management. A new research poster, presented at the European OHDSI Symposium, introduces the SWEEP cohort and its goal to facilitate the future real-time integration of routine health data into pharmacovigilance signal management workflows.

Access the poster in our Research library today 👉 https://ow.ly/F1SO50YNqwO